Daño cerebral cuando la esclerosis múltiple es diagnosticada clínicamente.

Same author

Myelin antigen-specific effector CD8+ T cells induce chronic CNS autoimmunity in a CD4+ T cell-dependent manner.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same author

Erythrocyte Fragility in Progressive Multiple Sclerosis.

European journal of neurology·2026

Same author

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases.

JAMA neurology·2026

Same author

The functional role of glial cells in the pathologic brain as reviewed by Alois Alzheimer in 1910.

Molecular neurodegeneration·2026

Same author

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.

Acta neuropathologica·2026

Same author

The dynamics of brain T cell populations during the course of rasmussen encephalitis: from expansion to exhaustion.

Journal of neuroinflammation·2025

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Daño cerebral cuando la esclerosis múltiple es diagnosticada clínicamente.

Videos de Conceptos Relacionados

Myelin antigen-specific effector CD8+ T cells induce chronic CNS autoimmunity in a CD4+ T cell-dependent manner.

Erythrocyte Fragility in Progressive Multiple Sclerosis.

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases.

The functional role of glial cells in the pathologic brain as reviewed by Alois Alzheimer in 1910.

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.

The dynamics of brain T cell populations during the course of rasmussen encephalitis: from expansion to exhaustion.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Daño cerebral cuando la esclerosis múltiple es diagnosticada clínicamente.

Videos de Conceptos Relacionados

Artículos Relacionados

Myelin antigen-specific effector CD8+ T cells induce chronic CNS autoimmunity in a CD4+ T cell-dependent manner.

Erythrocyte Fragility in Progressive Multiple Sclerosis.

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases.

The functional role of glial cells in the pathologic brain as reviewed by Alois Alzheimer in 1910.

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.

The dynamics of brain T cell populations during the course of rasmussen encephalitis: from expansion to exhaustion.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.